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Edited by Jesus AvilaAbstract Regulatory protein kinases are involved in various
cellular processes such as proliferation, diﬀerentiation, and
apoptosis. Using cDNA diﬀerential display, we identiﬁed
MOK, a member of the mitogen-activated protein kinase
superfamily, as one of the genes induced by a caudal-related
homeobox transcription factor, Cdx2. Analysis of the 50-ﬂanking
region of the MOK gene led to the identiﬁcation of primary
Cdx2 responsive element, and an electrophoretic mobility shift
assay indicated that Cdx2 binds to that element. The interaction
of Cdx2 with the MOK promoter region was further conﬁrmed
in vivo by chromatin immunoprecipitation assays. The expres-
sion of MOK mRNA and protein was limited to the crypt
epithelial cells of the mouse intestine. We also determined the
MOK activity associated with the growth arrest and induction of
diﬀerentiation by sodium butyrate or Cdx2 expression in the
human colon cancer cell line HT-29. Taken together, these data
indicate that MOK is a direct target gene for Cdx2, and that
MOK may be involved in growth arrest and diﬀerentiation in the
intestinal epithelium.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cdx2 is a member of the caudal-related homeobox gene
family due to its sequence homology to the caudal gene of
Drosophila melanogaster [1]. This gene encodes a transcrip-
tional factor that plays an important role in the development
and homeostasis of the intestinal epithelium [2]. The Cdx2 gene
is expressed in the epithelial cells of the intestine and colon,
with undetectable levels in other tissues [1]. Cdx2 activates
intestinal-speciﬁc gene expression and may direct normal in-
testinal epithelial development and diﬀerentiation [3,4].* Corresponding author. Present address: Laboratory for Neuronal
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doi:10.1016/j.febslet.2004.07.070In order to further understand Cdx2 function in determining
the fate of epithelial cells in the intestine, we attempted to
identify downstream target genes regulated by Cdx2. Diﬀer-
ential display PCR approaches were used to characterize the
eﬀects on gene expression proﬁles following the overexpression
of Cdx2 in IEC-6 cells, an undiﬀerentiated intestinal cell line
with very low levels of endogenous Cdx2 expression. One gene
for MOK [5], a member of the Mitogen-activated protein
(MAP) kinase superfamily, was found to be activated follow-
ing Cdx2 overexpression. The MAP kinases are critical in
signal transduction pathways involved in the regulation of
cellular proliferation, diﬀerentiation, and apoptosis. MOK is
similar (about 40% identity) to previously identiﬁed protein
kinases, male germ cell-associated kinase (MAK; [6]), MAK-
related kinase (MRK; [7]), and intestinal cell kinase (ICK; [8]),
and possesses a Thr–Glu–Tyr (TEY) motif in the activation
loop domain similar to those of the classical MAP kinases.
However, MAP kinase-stimulating treatment of cells including
serum addition, anisomycin treatment, and osmotic shock did
not signiﬁcantly activate MOK [5], suggesting that MOK may
be indirectly involved in MAP kinase cascades, or possibly
serves as a component of a diﬀerent signal transduction
pathway. To date, the physiological functions of this kinase
remain largely unknown.
In the present study, a reporter gene assay, atomic force
microscopy (AFM), an electrophoretic mobility shift assay
(EMSA), and a chromatin immunoprecipitation assay (ChIP)
were performed to determine whether Cdx2 interacts with the
MOK promoter and upregulates MOK mRNA. Localization
of the MOK gene and protein in the intestine was observed by
RNA in situ hybridization and immunohistochemical staining.
These ﬁndings may provide insight into important roles played
by MOK in the diﬀerentiation of intestinal epithelial cells.2. Materials and methods
2.1. Cell culture
The rat intestinal cell line, IEC-6, and the human colon cancer cell
line, HT-29, were obtained from RIKEN Bioresource Center (Tsu-
kuba, Japan) and from ATCC (Manassas, VA), respectively. IEC-6
cells were maintained under an atmosphere of 5% CO2 at 37 C in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 5% fetal
calf serum (FCS; P.A.A. Wiener Strasse, Linz, Austria), 0.1 units/ml
insulin, 100 units/ml of penicillin, and 100 lg/ml streptomycin (Invit-
rogen, Grand Island, NY). HT-29 cells were grown in DMEM
containing 10% FCS. Upon reaching 90% conﬂuency, cells wereblished by Elsevier B.V. All rights reserved.
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dium butyrate (Wako, Kyoto, Japan) was used at a ﬁnal concentration
of 4 mM. The stably transfected cell line that expresses Cdx2 condi-
tionally was established with the Tet-Oﬀ Gene Expression System (BD
Biosciences Clontech, Palo Alto, CA, USA) as described previously [9].
2.2. RT-PCR
RT-PCR was performed with oligo-dT-primed cDNA. Gene-speciﬁc
primers, Cdx2, glyceraldehyde-3-phosphate dehydrogenase (G3PDH),
MOK, and ICK primers were designed as follows: Cdx2 forward, 50-
GGCGAAACCTTTGTGAATGG-30; Cdx2 reverse, 50-GTGAAATT-
CCTTCTCCAGCTCC-30; G3PDH forward, 50-ACCACAGTCCAT-
GCCATCAC-30; G3PDH reverse, 50-TCCACCACCCTGTTGCTG-
TA-30; rat MOK forward, 50-CGGAGTGTCTATTCCAAGC-30; rat
MOK reverse, 50-CATTCACACCAGGAAAGAG-30; human MOK
forward, 50-GAGCTAATACGAGGGAGAAG-30; human MOK
reverse, 50-TCAGTAGAGGTATTCCTGATCC-30.
Northern blot analysis. For each sample, 10 lg of total RNA was
separated on 1% formaldehyde-agarose gel and transferred to Hy-
bond-Nþ (Amersham, Buckinghamshire, UK) by capillary action in
20 SSPE buﬀer (where 1 SSPE was 0.149 M NaCl, 0.001 M EDTA,
and 0.01 M phosphate buﬀer, pH 7.7) for 12 h. Membranes were rinsed
in 2 SSC (1 SSC is 0.149 M NaCl and 0.015 M sodium citrate, pH
7.0) and were brieﬂy air-dried, and the RNA was cross-linked by UV
irradiation. An anti-sense cRNA probe labeled with digoxigenin was
generated from 161 bp of the PCR products (448–619) of MOK in-
serted into the pGEM-T Easy vector (Promega, Madison, WI) using a
Dig RNA labeling kit (Roche Diagnostic, Indianapolis, IN) by means
of in vitro transcription. After prehybridization, the membranes were
hybridized overnight at 65 C in a Rapid-hyb buﬀer (Amersham)
containing the DIG-labeled probe and 0.1 mg/ml denatured salmon
sperm DNA (Sigma, St. Louis, MO). Membranes were then washed
twice with 2 SSC and 0.05% sodium dodecyl sulfate (SDS) at 58 C
for 20 min, as well as twice with 0.1 SSC and 0.1% SDS at 50 C for
30 min. DIG detection was performed by using a DIG Luminescent
Detection Kit, as described by the manufacturer (Roche Diagnotics).
2.3. Reporter assay
The 50-ﬂanking region of the human MOK gene between +183 and
)677 was obtained from a human BAC clone 59L23 (Invitrogen). The
DNA fragments of the MOK genomic clone were obtained by PCR,
conﬁrmed by sequence analysis, and subcloned into the multiple-
cloning site of the promoterless vector pGL3 basic (Promega) to
generate the reporter constructs pGL3/MOK 677 ()677/+183), pGL3/
MOK 340 ()340/+183), pGL3/MOK 101 ()101/+183), and pGL3/
MOK 77 ()77/+183). Preparation of mouse sucrase-isomaltase (SI)
promoter-luciferase vector (pGL3/SI 130) was described previously [9].
The mutant reporter vectors, in which Cdx2-binding element from )84
to )88 (50-TTTAC-3) is disrupted (50-TGCAC-3), were constructed
from pGL3/MOK 340 and pGL3/MOK 677 using a site-directed
mutagenesis kit, QuickChange (Stratagene, La Jolla, CA). For the
luciferase assay, HT-29 Tet-Oﬀ/Cdx2 cells plated 24 h prior to trans-
fection at 2 105 cells/well in 60 mm-well plates were co-transfected
with 1 lg of the ﬁreﬂy luciferase reporter plasmid and 50 ng of the
Renilla luciferase reporter plasmid pRL-TK (Promega) by using Ef-
fectene according to the manufacturer’s instructions (Qiagen, Hilden,
Germany). After 24 h of incubation, the cells were lysed in lysis buﬀer
supplied by the manufacturer, followed by measurement of the ﬁreﬂy
and Renilla luciferase activities on a luminometer TD-20/20 (Turner
Designs, Sunnyvale, CA). The relative ﬁreﬂy luciferase activities were
calculated by normalizing the transfection eﬃciency according to the
Renilla luciferase activities. The experiments were performed in trip-
licate and similar results were obtained from at least three independent
experiments.
A full-length, wild-type human Cdx2 and Cdx1 were ampliﬁed by
RT-PCR from normal human colon total RNA. The Cdx2 and Cdx1
cDNA were inserted into the multiple cloning site of the expression
vector pcDNA3.1 (Invitrogen). Transfection of cells at 60–80% con-
ﬂuency was performed with Eﬀectene, pGL3/MOK 677, pRL-TK, and
pcDNA3.1/Cdx2 or pcDNA3.1/Cdx1. At 24 h after transfection, cells
were collected for luciferase assay.
2.4. Atomic force microscopy experiments
pGL3/MOK677 was digested to obtain the EcoRI fragment, which
was subjected to 2% agarose gel electrophoresis. An 800 bp DNA bandwas then cut and puriﬁed using Wizard SV Gel and PCR Clean-Up
System (Promega). The puriﬁed DNA sample was heated at 60 C for 5
min and then rapidly cooled on ice. Puriﬁed Cdx2 protein and b-ga-
lactosidase was mixed with the DNA in 10 mM Tris–HCl buﬀer (pH
7.2) for 5 min at room temperature and diluted 50 times to ﬁnal
concentrations of 8 nM DNA and protein. Aliquots (10 ll) of the
mixture were then dripped onto a mica substrate coated with spermine,
rinsed with 1 ml of water, and blown with dry nitrogen gas. AFM
analysis was carried out using a Nanoscope IIIa Multimode system
(Digital Instruments Inc., Santa Barbara, CA, USA) in the tapping
mode at room temperature in air. Silicon cantilevers of 125 lm in
length with a spring constant of 42 N/m were purchased from Nano-
World (Neucha^tel, Switzerland). Typical resonant frequencies of these
tips were 320 kHz. The 512 512 pixel images were collected at a rate
of two scan lines per second. The contour lengths of the protein-DNA
complex were determined using Image Gauge (FUJIFILM, Tokyo,
Japan).
2.5. Electrophoretic mobility supershift assay
Nuclear extracts were obtained as described previously [10]. Cells
were harvested and resuspended in buﬀer A (10 mM HEPES/KOH,
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT),
and Protease Inhibitor Cocktail; Sigma). The supernatant was re-
moved by centrifugation at 600· g for 5 min and the nuclear pellet was
resuspended in buﬀer B (20 mM HEPES/KOH, pH 7.9, 1.5 mM
MgCl2, 420 mM NaCl, 0.2 mM EDTA, and Protease Inhibitor
Cocktail). The Cdx2 binding consensus region probe consisted of a
double-stranded 30 bp oligonucleotide (50-GATTTGCACAGTAT-
TTACATGGAAGCGGAG-30) from )101 to )72 of the human MOK
gene. The sequence of the mutant oligonucleotide was 50-GAT-
TTGCACAGTATGCACATGGAAGCGGAG-30. The probes were
labeled with a DIG Oligonucleotide labeling kit (Roche Diagnostics)
according to the manufacturer’s instructions. The nuclear extract (2
lg) was incubated in the presence of 1 ng DIG-labeled probe with 0.5
lg poly dI–dC, 5 mM HEPES/KOH, pH 7.9; 0.25 mM KCl, 0.05 mM
EDTA, 0.125 mM PMSF, 10% glycerol, and 100 lg/ll salmon testis
DNA, for 15 min at room temperature. DNA–protein complexes were
loaded on 6% polyacrylamide gel. For DIG detection, gels were
transferred by electroblotting for 30 min at 40 mA to Hybond-Nþ
membranes. DIG detection was performed as described by the man-
ufacturer (Roche Diagnotics). Mouse monoclonal anti-Cdx2 antibody
(BioGenex, San Ramon, CA) was used to detect Cdx2 protein.
2.6. Chromatin immunoprecipitation assay
HT-29 cells were transfected with Cdx2 expression plasmid con-
taining a human cytomegalovirus promoter and Cdx2 open reading
frame or vector alone. Chromatin immunoprecipitation assays were
performed according to the manufacturer’s recommendations (Upstate
Biotech, Lake Placid, NY, USA). In brief, 24 h after transfection,
cellular chromatin was cross-linked to the DNA by adding formalde-
hyde to a ﬁnal concentration of 1%. Precipitated chromatin was in-
cubated with the anti-Cdx2 antibody overnight at 4 C. Then, the
immune complexes were recovered by the addition of 60 ll of salmon
sperm DNA/protein G-sepharose slurry, followed by incubation for 1
h at 4 C. After washing the beads, the immune complexes were eluted
by incubation for 15 min at 25 C with 500 ll of elution buﬀer (1%
SDS, 100 mM NaHCO3, and 10 mM dithiothreitol (DTT)). To reverse
the cross-linking of DNA, elutes were added to 50 ll of 5 M NaCl and
incubated for 4 h at 65 C, followed by treatment with proteinase K for
1 h at 45 C. Quantitative PCR was carried out for 35 cycles using 5 ll
of sample DNA solution and the PCR products were separated on 2%
agarose gels in 1 Tris-acetate/EDTA.
2.7. In situ hybridization
Four- to six-week-old mice were sacriﬁced and the duodenum and
ileum were surgically dissected. These tissues were ﬁxed in Bouin’s
solution and processed through a standard embedding protocol. A
series of 4-lm sections were cut for analysis. Hybridization was carried
out in a hybridization solution containing 50% formaldehyde, 1
Denhardt’s solution, 300 mMNaCl, and 30 mM sodium citrate kept at
50 C overnight. Hybridized DIG-labeled cRNA was detected with an
alkaline phosphatase-conjugated anti-DIG Fab fragment antibody
(Roche Diagnotics), and the signals were visualized using 4-nitro blue
tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphatase
(Roche Diagnotics) as the chromogenic substrates.
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Following the manufacturer’s instructions, we used the Vectastain
Universal Quick kit (Vector Laboratories, Burlingame, CA) to detect
primary antibodies on mouse tissue. Formalin-ﬁxed, paraﬃn-embed-
ded tissues were deparaﬃnized and hydrated. Antigen enhancement
was performed by boiling the slides in a microwave oven for 6 min in
10 mM citrate buﬀer (pH 6.0). Endogenous peroxidase activity was
blocked by 0.3% hydrogen peroxide in methanol for 20 min. After
being washed and incubated with blocking reagent for 1 h, the slides
were incubated with primary antibody for 1 h at room temperature.
Mouse monoclonal anti-Cdx2 antibody (BioGenex) and rabbit poly-
clonal anti-MOK antibody (generously provided by Dr. Yoshihiko
Miyata, Kyoto University) were used at 1:500 and 1:250 dilution, re-
spectively. Sections were counterstained with hematoxylin and were
then evaluated by light microscopy.
2.9. In vitro protein kinase assay
The open reading frame encoding for mouse MOK was inserted into
a pENTR vector (Invitrogen) and then inserted into a pDEST 26
plasmid (Invitrogen) to obtain 6 His-tagged MOK. Plasmids were
introduced into HT-29 cells by Eﬀectene. The puriﬁcation of 6 His-
tagged protein was performed by anti-6 His and anti-MOK immu-
noprecipitation. The lysates were mixed with antibodies against 6
His-tag or MOK overnight. Protein G-Sepharose (Amersham) sus-
pension (50%) was added to the mixture, which was further incubated
at 4 C for 90 min. The antibody-bound beads were washed thoroughly
and were used for the in vitro protein kinase assay. Myelin basic
protein (MBP), a substrate for phosphorylation, and PhosphoThreo-
nine Antibody for the immunodetection of phosphorylated proteins
were purchased from Upstate and Qiagen, respectively. To test the
phosphorylation of MBP by MOK kinase, MBP was incubated with
MOK at 30 C for 60 min (50 mM Tris–HCl, pH 8.0, 100 mM NaCl,
and 20 mM b-glycerophosphate). The ﬁnal composition of the kinase
assay mixture was 0.04 mM ATP. Reactions were stopped by the
addition of SDS sample buﬀer to the samples, which were boiled for 5
min. The phosphorylation of the proteins was analyzed by Western
blot analysis.3. Statistics
All of the results are presented as the means S.E. Data
were analyzed using the Mann–Whitney U test. StatisticalFig. 1. Induction of MOK gene expression by Cdx2. (A) Diﬀerential display
grown in the presence and absence of induction medium (Dox-free) and the
pressed cDNA, which was isolated for reampliﬁcation. (B) Eﬀects of Cdx2 ex
HT-29 cells (ii). Total RNAs were isolated from IEC-6 Tet-Oﬀ/Cdx2 cells or
24 h and were analyzed by semi-quantitative RT-PCR. PCR was performed f
in IEC-6 Tet-Oﬀ/Cdx2 cells treated with (Dox+) or without (Dox)) for 24 h
SDS–10%PAGE. A polyclonal MOK antibody detects the roughly 46 kDa M
basal solution (+).values of P < 0:05 were considered signiﬁcant. Statistical
analysis was performed with SPSS software (SPSS, Chicago,
IL).4. Results
4.1. MOK expression induced by Cdx2
We previously demonstrated that the induction of Cdx2
expression in IEC-6 cells, an undiﬀerentiated rat intestinal
epithelial cell line, results in the expression of various genes [9].
To identify other genes that are induced by Cdx2, we used the
cDNA diﬀerential display method to compare patterns of
mRNA expression between IEC-6 cells that express Cdx2 and
those that do not. For these experiments, we used the IEC-6
Tet-Oﬀ/Cdx2 cell line that we engineered to conditionally
express Cdx2 when doxycycline (Dox) was removed from the
culture medium [10]. Under one condition of diﬀerential dis-
play, PCR ampliﬁcation was performed with the primers
50-CATTATGCTGAGTGATATCTTTTTTTTTGA-30 and
50-ATTAACCCTCACTAAATGCTGGTGG-30. A band was
detected in the lane of IEC-6 Tet-Oﬀ/Cdx2 cells expressing
Cdx2, but not in the lane of uninduced cells (Fig. 1A). Ap-
proximately 260-bp cDNA was reampliﬁed, subcloned, se-
quenced, and identiﬁed as the 30-untranslated region of the rat
MOK mRNA. The diﬀerential expression of MOK was char-
acterized further by RT-PCR and Northern blot analysis
(Fig. 1B and C). IEC-6 Tet-Oﬀ/Cdx2 cells cultured in medium
containing Dox expressed very low levels of MOK mRNA. By
24 h after the induction of Cdx2 expression, two transcripts
were observed, which were approximately 2.0 and 4.0 kb, re-
spectively. An additional larger band was reported in the
heart, brain, kidney, and pancreas [5]. It is possible that the
larger transcript may have resulted from alternative splicing or
cross-hybridizing a diﬀerent member of the MOK family. The
Cdx2-induced MOK gene expression was also observed inanalysis of IEC-6 Tet-Oﬀ/Cdx2 mRNA. IEC-6 Tet-Oﬀ/Cdx2 cells were
RNA was isolated after 1 day. The arrow indicates diﬀerentially ex-
pression on MOK gene induction in the rat IEC-6 cells (i) and human
HT-29 Tet-Oﬀ/Cdx2 cells treated with Dox (+) or vehicle alone ()) for
or 30 cycles for ampliﬁcation. (C) MOK and Cdx2 proteins expression
. Equal amounts of protein from cellular extracts were fractionated by
OK protein in the Cdx2-induction medium ()) for 24 h but not in the
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(Fig. 1D).4.2. Identiﬁcation of one Cdx2-responsive region in the MOK
promoter
To determine whether or not the MOK gene is a potential
target of Cdx2 transactivation, the ability of the human MOK
promoter to drive transcription in HT-29 cells was tested using
various lengths of the 50-ﬂanking region of the human MOK
gene linked to the luciferase reporter gene (Fig. 2). Within the
677-bp 50-ﬂanking region of the MOK gene contained in the
pGL3/MOK 677 plasmid, there were three Cdx2-binding ele-
ment-like regions (TTTAC/T; [2,11]). The pGL3/MOK 340
and pGL3/MOK 101 plasmids contained only one Cdx2-
binding element-like region. Fig. 3A shows the eﬀects of Cdx2
expression on human MOK gene promoter activity. The basal
promoter activities of those 50-ﬂanking regions of the human
MOK gene were quite low. The minimal MOK promoter,
containing )77 to +183, was not able to activate transcription.
Removal of the sequence containing the Cdx2 binding ele-
ments between )677 and )340 did not change the Cdx2-
induced activation of the promoter. The mutant (pGL3/MOK
340 Mut and pGL3/MOK 101 Mut), in which the Cdx2-
binding element from )84 to )88 (50-TTTAC-3) was disrupted


















Fig. 2. Structure of the MOK promoter-luciferase fusion plasmids. The pG
MOK 101 ()101/+183) plasmids contained 677-, 340-, and 101-bp fragments,
the exon 1 untranslated region, linked to a luciferase reporter. Cdx2-respons
shown (n). The plasmid pGL3-Basic is a negative control plasmid containinAnother caudal-related homeobox gene, Cdx1, has the same
homeodomain, which binds the same DNA sequence as Cdx2.
We examined whether MOK was speciﬁc target of Cdx2 or
was common downstream target of both Cdx2 and Cdx1. As
shown in Fig. 3B, both of the Cdx2 and Cdx1 expression led to
active transcription signiﬁcantly by the minimal sucrase-
isomaltase promoter containing one Cdx-binding motif. On
the other hand, Cdx2 expression activates transcription by the
MOK promoter signiﬁcantly, whereas the Cdx1 expression
exhibited quite a low transcription activity.
4.3. In vitro protein interaction with the Cdx2-responsive
elements
An 800-bp DNA fragment of the MOK promoter (Fig. 4A)
and Cdx2 protein were used for Nanoscope III AFM, which
made Cdx2:DNA complexes images. Under the binding con-
dition with b-galactosidase (100 kDa; as non-speciﬁc control),
most of the DNA molecules appear with no protein attached
(Fig. 4B, i). A typical image of Cdx2 interacting with MOK
promoter DNA is shown in Fig. 4B, ii–iv. Most of the DNA–
protein complexes showed one protein complex (ii and iii).
Three protein complexes were not very often observed (iv). To
further determine whether or not Cdx2 proteins in IEC-6 Tet-
Oﬀ/Cdx2 cells bind to the caudal motif of the human MOK
promoter gene, we incubated DIG-labeled DNA containing
the caudal motif 1 and nuclear extracts from IEC-6 Tet-Oﬀ/
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Fig. 3. Eﬀects of Cdx2 expression on human MOK gene promoter
activity. (A) Key Cdx2-responsible element for MOK transcription in
HT-29 cells. Mutation was introduced to the Cdx2-responsive element-
like sequences in the MOK gene promoter within the pGL3/MOK 340
and pGL3/MOK 101 plasmids, and the mutant reporter plasmids
(pGL3/MOK 340 Mut and pGL3/MOK 101 Mut) were obtained.
Luciferase activity was measured in HT-29 Tet-Oﬀ/Cdx2 cells co-
transfected with the pRL-TK Renilla luciferase reporter and various
luciferase reporters, as indicated in Fig. 2. The ratio of ﬁreﬂy luciferase
activity to control Renilla luciferase activity is indicated (in arbitrary
units), in response to the expression of Cdx2 (j) or no induction ().
All experiments are expressed as the means S.E. of triplicate cultures.
(B) Luciferase assay of human MOK promoter ()677/+183) and
minimal mouse SI promoter ()130/+45) in response to Cdx2 or Cdx1.
MOK or SI promoter-luciferase constructs (pGL3/MOK 677 or
pGL3/SI 130) were transfected into HT-29 cells with the pRL-TK and
pcDNA3.1/Cdx2 or pcDNA3.1/Cdx1. Results are expressed as
meansS.E. of four independent experiments.
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complex of slower mobility was detected. Cdx2-antibody rec-
ognized the nuclear protein bound to the Cdx2-region probe,
resulting in a reduction in gel mobility. Unlabeled oligonu-
cleotide provided in 100-fold excess could compete to the DIG-
labeled probe, whereas an excess of mutant oligonucleotide
was not able to compete for nuclear protein binding, which
was recognized by Cdx2 antibody (resulting in a reduction of
gel mobility).
4.4. Identiﬁcation of proteins interacting in vivo with the
Cdx2-responsive region
Since the EMSA performed on the Cdx2-responsive region
in the MOK promoter provided clear evidence of the interac-
tion of Cdx2 with that site in vitro, we further conﬁrmed to
assessed protein interactions with the responsive sequence in
vivo using a chromatin immunoprecipitation (ChIP) assay.Protein-DNA complexes crosslinked by treatment with form-
aldehyde were immunoprecipitated with Cdx2 antibody. The
DNA fragment of the 50-ﬂanking region of MOK could be
ampliﬁed by PCR (Fig. 4D), as was the positive control (In-
put), whereas that immunoprecipitated without antibody was
not ampliﬁed by PCR (No antibody). The speciﬁcity of the
recovery of these promoter regions following ChIP with anti-
Cdx2 antibody was veriﬁed by the fact that other irrelevant
DNA fragments lacking Cdx2 binding sites (e.g., the G3PDH
gene) were not recovered. These results indicate that Cdx2
binds directly to the MOK promoter.
4.5. MOK expression in the intestinal crypt
Small intestine tissue was subjected to RNA in situ hybrid-
ization with mouse MOK sense and antisense probes. These
probes were generated to avoid potential cross-reactivity with
other kinases. The hybridization of the antisense MOK probe
was detected speciﬁcally in the crypt compartment of the small
intestine (Fig. 5A), whereas the sense MOK probe was not
detected (Fig. 5B). We also examined the expression of MOK
protein in the mouse small intestine and stomach. In the in-
testine, Cdx2-positive epithelial cells were observed, except for
in the lower portion of crypts containing Paneth cells
(Fig. 5C). Similarly, MOK protein was detected in the intes-
tinal epithelial cells (Fig. 5D), whereas Cdx2 and MOK ex-
pression was not detected in the epithelial cells of normal
stomach tissue (Fig. 5E). Although the highly predominant
immunostaining of MOK protein was observed within the
lamina propria, this staining was seen in the control experi-
ment with preimmune serum or biotin-streptavidin detection
kit (data not shown). Therefore, the staining in the lamina
propria seems to be non-speciﬁc.
4.6. MOK is activated in response to butyrate and Cdx2
expression
The phosphorylation of both Threonine and Tyrosine resi-
dues of the TEY sequence in the activation loop of MOK is
necessary for the activation of MOK. However, upstream ac-
tivators or extracellular stimuli were not readily apparent,
suggesting that MOK may be involved indirectly in MAP ki-
nase cascades. We examined the phosphorylation of MOK
protein in response to butyrate treatment and to Cdx2 induc-
tion for 24 and 48 h. Butyrate, which is derived from the mi-
crobial metabolism of dietary ﬁber in the colon, has been
reported to inhibit growth and induce diﬀerentiation and ap-
optosis in HT-29 cell lines [12,13]. Similarly, forced expression
of the Cdx2 gene has been also reported to reduce proliferation
and cause morphological changes in HT-29 cell lines [14]. The
activation of transfected MOK by sodium butyrate or Cdx2
induction in the HT-29 cells is shown in Fig. 6A and B. In the
HT-29 cells, the level of MOK phosphorylation and kinase
activity (the phosphorylation of MBP, a target for phosphor-
ylation by MOK) gradually increased after butyrate treatment
or Cdx2 induction. On the other hand, Cdx2 expression in
IEC-6 cells tended to stimulate cell proliferation instead of
growth arrest [9,10]. In IEC-6 cell line, MOK phosphorylation
did not increase signiﬁcantly after Cdx2 induction (data not
shown). Further investigation is necessary for understanding
activation of MOK in the cell growth, diﬀerentiation or ap-
optosis of intestinal epithelial cells.
We tested whether the cell cycle arrest induced by Cdx2
expression is aﬀected by transfection of the MOK dominant
Fig. 4. Direct interaction of Cdx2 in the promoter region of the MOK gene. (A) Schematic picture of the MOK promoter showing three Cdx2-
binding motifs. (B) AFM image of complexes of 800-bp DNA fragment of MOK promoter with b-galactosidase (i) Cdx2 protein (ii–iv; arrowheads).
The images were acquired using a tapping mode AFM in air. The distinct light spot observed on the DNA molecules, which are marked with ar-
rowheads, is bound Cdx2 protein. (C) Gel supershift assay with HT-29 Tet-Oﬀ/Cdx2 cell nuclear extracted, Cdx2 region probe, Cdx2-region mutant
probe, and anti-Cdx2 antibody. DIG-labeled probes (wildtype or mutant) were incubated with nuclear extracts alone, or in the presence of excess of
unlabeled oligonucleotide or Cdx2 antibody, and were separated on 6% non-denaturing polyacrylamide gel. DIG-labeled probes were incubated with
nuclear extract Western blotting analysis of MOK and Cdx2 protein levels were added in Fig 1C. The early induction of the MOK protein was not
observed (data not shown). Therefore, MOK gene induction was also observed 24 h after Cdx2 expression. Similar results were obtained from other
two independent experiments. (D) Cdx2 binding to the MOK promoter region is shown by chromatin immunoprecipitation assay. The protein-DNA
complexes were incubated with monoclonal antibodies against Cdx2 and were isolated by immunoprecipitation. PCR was performed for 35 cycles for
the ampliﬁcation of a 284-base MOK 50-ﬂanking region DNA fragment.
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residue for kinase activity). However, a remarkable eﬀect was
not observed (data not shown).5. Discussion
To identify new molecules that may play important roles in
aﬀecting Cdx2 function in intestinal epithelial cells, we em-
ployed diﬀerential display PCR to identify genes induced fol-
lowing the overexpression of Cdx2 in a rat undiﬀerentiated
intestinal cell line, IEC-6, that has low levels of endogenous
Cdx2 expression. The present study identiﬁed the MOK gene
as a target for Cdx2. The rapid induction of MOK mRNAupon expression of Cdx2 in IEC-6 cells provided evidence that
the regulation of the MOK gene is part of a cascade of events
initiated by Cdx2 expression. Reporter gene assays allowed us
to demonstrate the important role of a consensus Cdx2 DNA-
binding element ()89 to )83) in the MOK promoter region in
the transcription of MOK. Subsequent EMSA assays revealed
that Cdx2 bound directly to the MOK promoter. The region
)89 to )83 appears to play a role in MOK gene regulation by
Cdx2. The ChIP assays performed here demonstrated that
Cdx2 binds directly to the MOK promoter in vivo.
Immunohistochemical and in situ hybridization studies re-
vealed that MOK localizes to intestinal crypt regions. The
crypt compartment is associated with proliferation and it is
from this compartment that cells ultimately diﬀerentiate into
Fig. 5. Mouse MOK localizes to intestinal crypt regions by RNA in situ hybridization. An antisense (A) and sense (B) probe for the mouse MOK
fragment was used (see Section 2). No signiﬁcant signal was detected with the sense probe that served as a control. The scale bar is 50 lm. Im-
munohistochemical analyses of Cdx2 (C) andMOK protein expression (D) in the mouse intestine and stomach tissue (E). Immunohistochemistry was
performed on formalin-ﬁxed and paraﬃn-embedded tissue using mouse monoclonal anti-Cdx2 and rabbit polyclonal anti-MOK antibodies. Brown
cells show positive immunostaining. Nuclear staining for Cdx2 was present in the normal intestinal epithelial cells. MOK expression was detected
primarily in the crypt of intestine. Cdx2 and MOK expression was not detected in the normal stomach epithelial cells. The scale bar is 50 lm.
T. Uesaka, N. Kageyama / FEBS Letters 573 (2004) 147–154 153diﬀerent lineages. Similarly, localization of related kinases may
bring a clue about those functions. MAK is expressed in tes-
ticular germ cells at stages around meiotic cell division [15] and
MRK, by virtue of expression in cardiac myocytes, has been
implicated in development [7]. In HT-29 cells, which closely
resemble intestinal crypt cells [16], butyrate addition resulted
in terminal diﬀerentiation and a decrease in extracellular sig-
nal-regulated protein kinases (ERKs) phosphorylation [17–19].
The present study revealed that butyrate treatment caused
phosphorylation of MOK and an increase in its kinase activity
in HT-29 cells. The activation of MOK activity was also in-
duced by the expression of Cdx2, which leads to the arrest of
proliferation and then induces diﬀerentiation [4]. MOK may
play a role in the processes of growth arrest and diﬀerentiation
in upper crypt and lower villus cells. The upstream modulators
and the physiological substrates of MOK remain to be
clariﬁed.MOK shares about 40% homology with ICK, which is ex-
pressed in the intestinal crypt [8]. The 50-ﬂanking region of the
human ICK gene contains several Cdx2-binding consensus
sites, suggesting that its expression may also be, at least in part,
regulated by Cdx2. The semi-quantitative RT-PCR analysis
performed here revealed that the expression of the ICK gene
was also induced by Cdx2 expression (data not shown). It is
thus increasingly clear that the same pattern of MAP kinase
signaling is used by more than one pathway employing the
sequential activation of distinct isoforms at each level of the
cascade. It will be interesting to identify the upstream kinase
and the physiological substrates of MOK and ICK in the in-
testinal epithelium.
In conclusion, we demonstrated that Cdx2 protein directly
binds to the MOK promoter and enhances MOK gene ex-
pression. MOK localizes to the intestinal crypt epithelial cells
and might be activated by diﬀerentiation process. MOK kinase
Fig. 6. Activation of MOK by butyrate treatment (A) or Cdx2 in-
duction in HT-29 cells (B). Anti-MOK immunoprecipitates were pre-
pared from MOK-transfected HT-29 cells treated with 4 mM sodium
butyrate or in the presence of the medium for the induction of Cdx2
expression. (i) The same immunoprecipitates of MOK were probed by
Western blotting with anti-MOK antibody. (ii) The phosphorylation
of MOK was detected by Western blot analysis with PhosphoThreo-
nine Antibody. (iii) The MBP phosphorylation activities by MOK were
investigated by Western blot analysis with PhosphoThreonine Anti-
body. Protein concentration was determined by a bicinchoninic acid
protein assay. Similar results were obtained from other two indepen-
dent experiments.
154 T. Uesaka, N. Kageyama / FEBS Letters 573 (2004) 147–154in the intestinal epithelium must be important to understand
the molecular mechanisms that underlie regulation of prolif-
eration and diﬀerentiation.
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